Lista de obras -

A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti–Zika Virus Vaccine

artículo científico publicado en 2021

A global approach to HIV‐1 vaccine development ⬇️

artículo científico publicado el 1 de julio de 2013

Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys

artículo científico publicado en 2016

Adenovirus serotype 5 vaccine vectors trigger IL-27-dependent inhibitory CD4+ T cell responses that impair CD8+ T cell function

artículo científico publicado en 2016

Antibody Responses After Analytic Treatment Interruption in Human Immunodeficiency Virus-1-Infected Individuals on Early Initiated Antiretroviral Therapy

artículo científico publicado en 2016

Attenuation of Replication-Competent Adenovirus Serotype 26 Vaccines by Vectorization

artículo científico publicado en 2015

Broadly Neutralizing Antibodies for HIV Eradication

artículo científico publicado en 2016

Chikungunya fever

artículo científico publicado en 2023

Common features of mucosal and peripheral antibody responses elicited by candidate HIV-1 vaccines in rhesus monkeys

artículo científico publicado en 2014

Comparison of shortened mosaic HIV-1 vaccine schedules: a randomised, double-blind, placebo-controlled phase 1 trial (IPCAVD010/HPX1002) and a preclinical study in rhesus monkeys (NHP 17-22)

artículo científico publicado en 2020

Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

artículo científico publicado en 2018

First-in-Human Randomized Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector

artículo científico publicado en 2018

First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1

scientific article published in PLoS ONE

Full-length HIV-1 immunogens induce greater magnitude and comparable breadth of T lymphocyte responses to conserved HIV-1 regions compared with conserved-region-only HIV-1 immunogens in rhesus monkeys

artículo científico publicado en 2012

Gag-specific cellular immunity determines in vitro viral inhibition and in vivo virologic control following simian immunodeficiency virus challenges of vaccinated rhesus monkeys

artículo científico publicado en 2012

HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design

article

HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design

scientific article published on 01 August 2019

Internet-enabled thyroid hormone abuse

artículo científico publicado en 2009

Neutralizing Antibody Responses following Long-Term Vaccination with HIV-1 Env gp140 in Guinea Pigs

artículo científico publicado en 2018

New concepts in HIV-1 vaccine development

artículo científico publicado en 2016

Persistence of endothelial thrombomodulin in a patient with infectious purpura fulminans treated with protein C concentrate

artículo científico publicado en 2018

Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor

artículo científico publicado en 2020

Preexisting adenovirus seropositivity is not associated with increased HIV-1 acquisition in three HIV-1 vaccine efficacy trials

artículo científico publicado en 2012

Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials

artículo científico publicado en 2017

Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys ⬇️

scientific article published on 24 October 2013

Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys

artículo científico publicado en 2016

Quantification of the epitope diversity of HIV-1-specific binding antibodies by peptide microarrays for global HIV-1 vaccine development

artículo científico publicado en 2014

Recurrent acute pancreatitis in anorexia and bulimia.

artículo científico publicado en 2004

Similar Epitope Specificities of IgG and IgA Antibodies Elicited by Ad26 Vector Prime, Env Protein Boost Immunizations in Rhesus Monkeys

artículo científico publicado en 2018

The quarantine war: the burning of the New York Marine Hospital in 1858.

artículo científico publicado en 2004

Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys

artículo científico publicado en 2013

Therapeutic vaccination for HIV: hopes and challenges

article

Zika virus vaccines

scholarly article by Peter Abbink et al published 19 June 2018 in Nature Reviews Microbiology

Lista de obras de

A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti–Zika Virus Vaccine

A global approach to HIV‐1 vaccine development ⬇️

Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys

Adenovirus serotype 5 vaccine vectors trigger IL-27-dependent inhibitory CD4+ T cell responses that impair CD8+ T cell function

Antibody Responses After Analytic Treatment Interruption in Human Immunodeficiency Virus-1-Infected Individuals on Early Initiated Antiretroviral Therapy

Attenuation of Replication-Competent Adenovirus Serotype 26 Vaccines by Vectorization

Broadly Neutralizing Antibodies for HIV Eradication

Chikungunya fever

Common features of mucosal and peripheral antibody responses elicited by candidate HIV-1 vaccines in rhesus monkeys

Comparison of shortened mosaic HIV-1 vaccine schedules: a randomised, double-blind, placebo-controlled phase 1 trial (IPCAVD010/HPX1002) and a preclinical study in rhesus monkeys (NHP 17-22)

Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

First-in-Human Randomized Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector

First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1

Full-length HIV-1 immunogens induce greater magnitude and comparable breadth of T lymphocyte responses to conserved HIV-1 regions compared with conserved-region-only HIV-1 immunogens in rhesus monkeys

Gag-specific cellular immunity determines in vitro viral inhibition and in vivo virologic control following simian immunodeficiency virus challenges of vaccinated rhesus monkeys

HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design

HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design

Internet-enabled thyroid hormone abuse

Neutralizing Antibody Responses following Long-Term Vaccination with HIV-1 Env gp140 in Guinea Pigs

New concepts in HIV-1 vaccine development

Persistence of endothelial thrombomodulin in a patient with infectious purpura fulminans treated with protein C concentrate

Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor

Preexisting adenovirus seropositivity is not associated with increased HIV-1 acquisition in three HIV-1 vaccine efficacy trials

Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials

Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys ⬇️

Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys

Quantification of the epitope diversity of HIV-1-specific binding antibodies by peptide microarrays for global HIV-1 vaccine development

Recurrent acute pancreatitis in anorexia and bulimia.

Similar Epitope Specificities of IgG and IgA Antibodies Elicited by Ad26 Vector Prime, Env Protein Boost Immunizations in Rhesus Monkeys

The quarantine war: the burning of the New York Marine Hospital in 1858.

Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys

Therapeutic vaccination for HIV: hopes and challenges

Zika virus vaccines